Core Cap Advisors, LLC Brainstorm Cell Therapeutics Inc. Transaction History

Core Cap Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Aug 08, 2024	BUY	$0.28 - $0.66 $37 - $87	133 New	133 $0
Q4 2022 Feb 10, 2023	BUY	$1.37 - $4.42 $182 - $587	133 New	133 $0
Q2 2022 Aug 11, 2022	BUY	$2.71 - $3.6 $360 - $478	133 New	133 $0
Q1 2022 Apr 29, 2022	SELL	$2.92 - $4.19 $388 - $557	-133 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$2.81 - $4.23 $373 - $562	133 New	133 $1,000

10.8M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $83.2M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Core Cap Advisors, LLC with notifications on news.